One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Magnetic Resonance Imaging–guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know
Linda G.W.KerkmeijeraAmar U.KishanbAlison C.Treec
Comparison of Typical Prostate Adenocarcinoma and Rare Histological Variant Prostate Cancer Showed Different Characteristics and Prognosis: A Surveillance, Epidemiology, and End Results Database Analysis
JiatongZhouJieDingJunQi
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography
Valentin H.Meissnera†IsabelRauscherb†KristinaSchwambornc†JanNeumanndGregorMillereWolfgangWeberbJürgen E.GschwendaMatthiasEiberbMatthias M.Hecka
Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative?
Parth K.ModiScott E.Eggener
Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort
Matthew B.ClementsaEmily A.VertosickbLourdesGuerrios-RiveracAmanda M.De HoedtdJavierHernandezeMichael A.LisseRobin J.LeacheStephen J.FreedlanddfAlexanderHaesegFrancescoMontorsihiStephen A.BoorjianjCedricPoyetkDonna P.AnkerstelAndrew J.Vickersb
Finding a Place for Family History To Inform High-grade Prostate Cancer Risk
Sarah C.MarktaKathryn L.PenneybcFredrick R.Schumachera
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
YohannLoriotaMatthieuTexierbStéphaneCulinecAudeFléchondAntoineThiery-VuillemineGwenaëlleGravisfLionelGeoffroisgChristineChevreauhMarineGross-GoupiliPhilippeBarthelemyjEmmanuelleBompaskHakimMahammedilBrigitteLaguerremSophie AbadieLacourtoisienCaroleHelisseyoSylvainLadoirepChristineAbrahamqChristopheMassardr…KarimFizazia
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria
Bhavan P.Raia†JoséLuis Dominguez Escrigb†LuÃsValecTeeleKuuskdOtakarCapouneViktorSoukupeHarman M.BruinsfYuhongYuangPhilippe D.ViolettehiNancySantessohjBas W.G.van RhijnkA.Hugh MostafidlMuhammadImran Omarm
Lingual Mucosal Graft Ureteroplasty for Long Proximal Ureteral Stricture: 6 Years of Experience with 41 Cases
ChaoqiLiangabc†JianliWangab†BoHaiab†YujieXud†JinminZengeShuaishuaiChaiabJiaweiChenabHaoZhangabXinchengGaoabGongChengabXiongYangabTengHouabWenchengLiabXingyuanXiaoabBingLiab
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study
DanielBurnsaEzequielAnokianaEdward J.SaundersaRobert G.BristowbMichaelFrasercdJüriReimanddeThorstenSchlommfGuidoSautergBenediktBrorshJanKorbeliJoachimWeischenfeldtfjSebastian M.WaszakklmNiall M.CorcorannopChol-HeeJungqBernard J.PopenrChris M.HovenspqsGéraldineCancel-TassintuOlivierCussenottu…Rosalind A.Eelesaanâ€
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
BernadettSzabadosabMarkKockxcZoe JuneAssafdPieter-Janvan DamcAlejoRodriguez-VidaeIgnacioDuranfSimon J.CrabbgMichiel S.Van Der HeijdenhAlbert FontPousiGwenaelleGravisjUrbano AnidoHerranzkAndrewProtheroelAlainRavaudmDenisMailletnMaria JoseMendezoCristinaSuarezpMarkLinchqAaronPrendergasta…ThomasPowlesa
Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)
MichaelKennellyaFranciscoCruzbSenderHerschorncPaulAbramsdKadirOnemeViktor KibanovSolomonovfElenadel Rosario Figueroa CozgAndreiManu-MarinhAntonellaGiannantoniiCatherineThompsonjClaireVilainkMagaliVolteaukPierreDenyslon behalf of the Dysport CONTENT Program Groupâ€
Robot-assisted Radical Prostatectomy with the Novel Hugo Robotic System: Initial Experience and Optimal Surgical Set-up at a Tertiary Referral Robotic Center
Carlo A.Braviabc†MarcoPaciottiabd†LucaSarchiabAngeloMottaranabeLuigiNoceraabcRuiFarinhabPieterDe BackerbMarie-HélèneVinckierabGeertDe NaeyerabFrederiekD'HondtabRubenDe GrooteabAlexandreMottrieab
Re: One-year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-coated Balloon for Anterior Urethral Strictures
Malte W.VetterleinaPhillipMarksaMargitFischaLuis A.KluthbTrauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists
Re: Multiparametric Ultrasound Versus Multiparametric MRI To Diagnose Prostate Cancer (CADMUS): A Prospective, Multicentre, Paired-cohort, Confirmatory Study
ArnasRakauskasMassimoValerioBeatRoth
Re: Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups
PiotrRadziszewskiAleksanderÅšlusarczyk
Re: Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience
AlbertoMartiniabGuillaumePloussardab
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer
EkaterinaLaukhtinaabShahrokh F.Shariatabcdefg
Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J Urol 2021;39:1911–6
PiotrRadziszewskiWaldemarSzabłoński
Re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
FredericPanthierabcdAlbaSierraabcOlivierTraxerabc
Reply to Frederic Panthier, Alba Sierra, and Olivier Traxer’s Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
ØyvindUlvikabMathiasSørstrand ÆsøyaPatrickJuliebø-JonesabPederGjengstøaChristianBeislandab
Re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
Hyung JoonKimKhurshid R.Ghani
Reply to Hyung Joon Kim and Khurshid R. Ghani’s Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
ØyvindUlvikabMathiasSørstrand ÆsøyaPatrickJuliebø-JonesabPederGjengstøaChristianBeislandab
Re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
Alan J.YaghoubianJohnathan A.KhusidMantuGupta
Reply to Alan J. Yaghoubian, Jonathan A. Khusid, and Mantu Gupta’s Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9
ØyvindUlvikabMathiasSørstrand ÆsøyaPatrickJuliebø-JonesabPederGjengstøaChristianBeislandab
Re: Jiatong Zhou, Jie Ding, Jun Qi. Comparison of Typical Prostate Adenocarcinoma and Rare Histological Variant Prostate Cancer Showed Different Characteristics and Prognosis: A Surveillance, Epidemiology, and End Results Database Analysis. Eur Urol. 2022;82:152–5
YuxuanSongYiqingDuTaoXu
Re: Longbin Xiong, Jane K. Nguyen, Yulu Peng, et al. What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy? Eur Urol. 2022;81:492–500. https://doi.org/10.1016/j.eururo.2021.12.036
ShangqingRenabShanZhongbcShidaFanacXinglanLicdFangZhouacDongWanga
Re: Ole Jacob Nilsen, Henriette Veiby Holm, Teresa O. Ekerhult, et al. To Transect or Not Transect: Results from the Scandinavian Urethroplasty Study, A Multicentre Randomised Study of Bulbar Urethroplasty Comparing Excision and Primary Anastomosis Versus Buccal Mucosal Grafting. Eur Urol. 2022;81:375–382
MazharOrtac
Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.007
YuWeiDingweiYeYaoZhu
TNM Staging of Prostate Cancer: Challenges in Securing a Globally Applicable Classification
AlejandroBerlinabJamesBrierleyabPhilipCornfordcPeterChungabEleniGiannopoulosdMalcomMasonefNicolasMottetgMaryGospodarowiczab
